To our investors
In equipment projects the order and the revenue fall in different periods, and projects run for a long time. Order backlog and progress have to be read together for the picture to be accurate.
Alongside the disclosures we are required to make, we publish the information needed for an investment decision here and on the disclosures page. Figures that are not confirmed are not published.
Business structure
| Segment | Characteristics |
|---|---|
| Standard equipment | Proven standard models. Shorter lead time and steadier margin. |
| Engineered to order | Designed for a specific process. Larger value and longer duration. |
| Line integration | Several machines with the cleanroom and utilities together. |
| Service | Service contracts, parts and training, accumulating with the installed base. |
Growth strategy
Grow service revenue
As the installed base grows, maintenance and parts follow. That revenue is less sensitive to the cycle.
Increase the sterile share
Equipment for injectables and sterile products has higher barriers to entry and higher unit value.
Extend the partner network
We widen coverage by pairing local partners with head office engineers.
Standardise the control software
A common control structure cuts both development time and the qualification burden.
Key indicators
| Order backlog | KRW 31.2 billion |
|---|---|
| Annual revenue | KRW 48.7 billion (2025) |
| Service share of revenue | 18% |
| Overseas share of revenue | 27% |
| R&D spend | 4.2% of revenue |
Figures are updated after the accounts are finalised, and the update date is shown with them.
Risk factors
- Customer investment cycles: orders can cluster or slip with pharmaceutical companies' capital plans.
- Project cost: material prices and exchange rates affect the cost of projects already under way.
- Regulatory change: when the rules change, design and documentation requirements change with them.
- People: the supply of design and validation engineers can limit how fast we grow.
IR contact
- EMAILinfo@shinwongpharma.com
- TELEPHONE+82-31-345-2180